Company profile · Biotech & medical
懷特生技新藥股份有限公司 · 4108
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
PhytoHealth is primarily engaged in the research, production, and manufacturing of new drugs, as well as the research and development of natural plants, Chinese herbal medicine ingredients, extraction and separation technology, and biochemical technology.[1]
The company's products include prescription drugs and health supplements approved by the Ministry of Health and Welfare, such as PG2 Lyo. Injection 500mg for cancer-related fatigue syndrome, Oraphine soft capsules for pain relief, and health foods like ReyeasCleanse and Energy Bean that help lower cholesterol.[2]
It also develops pipeline treatments including PHN033 for diabetic nephropathy and PHN031 for osteoporosis prevention.[2]
The company is based in Taipei, Taiwan.[1]
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$14m | +5.9% | +15.3% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$8m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | PhytoHealth Corporation |
|---|---|
| Chinese name | 懷特生技新藥股份有限公司 |
| Stock code | 4108 (TWSE) |
| Industry | Biotech & medical |
| Founded | 24 Nov 1998 |
| Listed | 16 Jul 2008 |
| Paid-in capital | NT$2.0bn |
| Chairman | 李伊俐 |
| President | 李伊伶 |
| Headquarters | FL.5-1,NO.167, FU HSING N. RD. TAIPEI,TAIWAN.R.O.C. |
| Website | https://www.phytohealth.com.tw |
| Official business description | 天然植物、中草藥成分、萃取分離技術、生化科技之研發 · 中草藥、原料藥及化學藥品之研發 · 醫藥品之顧問服務 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Generated 2026-11-11 00:39.